• 2023.12.05Timely Disclosure
  Notice of Allowance of New Use and Dosage Patent for PAI-1 Inhibitor(Title of the Invention: Inhibitor against Expression of Immune Checkpoint Molecule)(124KB)
• 2023.10.26Timely Disclosure
  Announcement of Initiation of Phase II Study for Cutaneous Angiosarcoma(144KB)
• 2023.10.19Timely Disclosure
  Announcement of Initiation of Phase II study for the treatment of interstitial lung disease associated with systemic scleroderma begins.(308KB)
• 2023.10.17Timely Disclosure
  Notice of Allowance of New Use and Dosage Patent for PAI-1 Inhibitor (Title of the Invention: Drug for Enhancing Fibrinolytic System, and Use Thereof)(135KB)
• 2023.09.26Timely Disclosure
  Announcement of Initiation of Phase II Study for Non-Small Cell Lung Cancer.(184KB)

IR News List